Options for Addressing the Dilemma of Managing Dense Breasts
Menée aux Etats-Unis et en Allemagne auprès de 1 444 femmes présentant une densité mammaire élevée et participant à un programme de dépistage du cancer du sein (âge médian : 54 ans), cette étude compare la performance, du point de vue du taux de détection de cancer invasif, d'une IRM mammaire avec protocole abrégé et d'une tomosynthèse numérique
Breast density on mammography is a well-documented risk factor for a future breast cancer diagnosis. This association, and the desire to empower women regarding knowledge of their individualized breast cancer risk, has motivated several dozen states to enact legislation mandating patient notification of mammographic density, and in February 2019, federal law directed the US Food and Drug Administration to oversee a mammographic density–reporting process for the entire country. Approximately 40% to 50% of women in the United States will be found to have heterogeneously or extremely dense breasts, and this frequency has remained stable despite incorporation of advances in screening mammography, such as digital breast tomosynthesis. A formidable outstanding challenge, therefore, is for clinicians and patients to interpret this information and incorporate it into follow-up health care.
JAMA Surgery , éditorial en libre accès, 2019